Varcov »

Taysha Gene Therapies shares owned by Varcov

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Varcov from 13F filings

Historical chart of Varcov investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Varcov consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Varcov

Quarter filed Position value Share count Share price at filing
2026-03-31 $262k 59k 4.47

More positions owned by Varcov

Ecovyst (ECVT)
WisdomTree Investments (WT)
Textron (TXT)
Cullen/Frost Bankers (CFR)
Healthcare Rlty Tr Cl A Com (HR)
KAR Auction Services (OPLN)
Freshworks Class A Com (FRSH)
Hub Group Cl A (HUBG)
Ingram Micro Hldg Corp (INGM)
Paylocity Holding Corporation (PCTY)
Resideo Technologies (REZI)
Granite Construction (GVA)
Oscar Health Cl A (OSCR)
Cintas Corporation (CTAS)
Worthington Industries (WOR)

View all positions for Varcov

Top funds holding Taysha Gene Therapies

RA Capital Management
Goldman Sachs Group
venBio Select Advisor
BlackRock
Vestal Point Capital
Morgan Stanley
Rtw Investments
FMR
Vanguard Group
State Street Corporation
Vanguard Capital Management
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays

View all funds holding Taysha Gene Therapies